TOPICS
2024/11/07
２１世紀におけるゼブラフィッシュ創薬のグローバル展開
2024/10/25
AIDXゼブラフィッシュ創薬のグローバル展開
2024/10/15
三重大学大学院システムズ薬理学の展開
2024/10/05
システムズ薬理学大学院大募集中です。
2024/09/10
Zebrafish-Based Oncocardionephrology
》第114号 三重大学 Flash News
2013/02/15
第114号 三重大学Flash Newsに12/27のPLoS ONE論文
記者会見の様子が掲載されました。
【新しい知見について研究成果発表】
食行動を制御する遺伝子と医薬品のハイスピード探索法開発に成功
A High-Throughput Fluorescence-Based Assay System for Appetite-Regulating Gene and Drug Screening
Yasuhito Shimada,Minoru Hirano, Yuhei Nishimura, Toshio Tanaka
Abstract
The increasing number of people suffering from metabolic syndrome and obesity is becoming a serious problem not only in developed countries, but also in developing countries. However, there are few agents currently approved for the treatment of obesity. Those that are available are mainly appetite suppressants and gastrointestinal fat blockers. We have developed a simple and rapid method for the measurement of the feeding volume of Danio rerio (zebrafish). This assay can be used to screen appetite suppressants and enhancers. In this study, zebrafish were fed viable paramecia that were fluorescently-labeled, and feeding volume was measured using a 96-well microplate reader. Gene expression analysis of brain-derived neurotrophic factor (bdnf), knockdown of appetite-regulating genes (neuropeptide Y, preproinsulin, melanocortin 4 receptor, agouti related protein, and cannabinoid receptor 1), and the administration of clinical appetite suppressants (fluoxetine, sibutramine, mazindol, phentermine, and rimonabant) revealed the similarity among mechanisms regulating appetite in zebrafish and mammals. In combination with behavioral analysis, we were able to evaluate adverse effects on locomotor activities from gene knockdown and chemical treatments. In conclusion, we have developed an assay that uses zebrafish, which can be applied to high-throughput screening and target gene discovery for appetite suppressants and enhancers.
関連リンク
A High-Throughput Fluorescence-Based Assay System for Appetite-Regulating Gene and Drug Screening